A T H 17-intrinsic IL-1β–STAT5 axis drives steroid resistance in autoimmune neuroinflammation
Science Immunology · 2024
DOI: 10.1126/sciimmunol.abq1558 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Immunology, 2024. Verfasst von William A Miller-Little und 11 weiteren Autor:innen. Beteiligte Einrichtung: Medical Scientist Training Program, Case Western Reserve University School of Medicine, Cleveland, OH, USA. Hauptthemen laut MEDLINE: Th17 Cells, STAT5 Transcription Factor, Interleukin-1beta, Encephalomyelitis, Autoimmune, Experimental. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Steroid resistance poses a major challenge for the management of autoimmune neuroinflammation. T helper 17 (T H 17) cells are widely implicated in the pathology of steroid resistance; however, the underlying mechanisms are unknown. In this study, we identified that interleukin-1 receptor (IL-1R) blockade rendered experimental autoimmune encephalomyelitis (EAE) mice sensitive to dexamethasone (Dex) treatment. Interleukin-1β (IL-1β) induced a signal transducer and activator of transcription 5 (STAT5)–mediated steroid-resistant transcriptional program in T H 17 cells, which promoted inflammatory cytokine production and suppressed Dex-induced anti-inflammatory genes. T H 17-specific deletion of STAT5 ablated the IL-1β–induced steroid-resistant transcriptional program and rendered EAE mice sensitive to Dex treatment. IL-1β synergized with Dex to promote the STAT5-dependent expression of CD69 and the development of central nervous system (CNS)–resident CD69 + T H 17 cells. Combined IL-1R blockade and Dex treatment ablated CNS-resident T H 17 cells, reduced EAE severity, and prevented relapse. CD69 + tissue-resident T H 17 cells were also detected in brain lesions of patients with multiple sclerosis. These findings (i) demonstrate that IL-1β–STAT5 signaling in T H 17 cells mediates steroid resistance and (ii) identify a therapeutic strategy for reversing steroid resistance in T H 17-mediated CNS autoimmunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Medical Scientist Training Program, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
- Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
- Department of Inflammation and Immunity, Cleveland Clinic Lerner Research Institute, Cleveland, OH, USA.
- Center for RNA Science and Therapeutics, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
- Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
- Neurology Section, VA North Texas Health Care System, Medical Service Dallas, Veterans Affairs Medical Center, Dallas, TX, USA.
ORCID-Profile: William A Miller-Little, Xing Chen, Vanessa Salazar, Caini Liu, Katarzyna Bulek, Julie Y Zhou, Olaf Stüve, Thaddeus Stappenbeck, George Dubyak, Junjie Zhao, Xiaoxia Li
Förderung
- NHLBI NIH HHS
Zitieren
APA
Miller-Little, W. A., Chen, X., Salazar, V., Liu, C., Bulek, K., Zhou, J. Y., Li, X., Stüve, O., Stappenbeck, T., Dubyak, G., Zhao, J., & Li, X. (2024). A T H 17-intrinsic IL-1β–STAT5 axis drives steroid resistance in autoimmune neuroinflammation. Science Immunology. https://doi.org/10.1126/sciimmunol.abq1558
Vancouver
Miller-Little WA, Chen X, Salazar V, Liu C, Bulek K, Zhou JY, et al. A T H 17-intrinsic IL-1β–STAT5 axis drives steroid resistance in autoimmune neuroinflammation. Science Immunology. 2024. doi:10.1126/sciimmunol.abq1558
BibTeX
@article{MillerLittle2024,
author = {Miller-Little, William A and Chen, Xing and Salazar, Vanessa and Liu, Caini and Bulek, Katarzyna and Zhou, Julie Y and Li, Xiao and Stüve, Olaf and Stappenbeck, Thaddeus and Dubyak, George and Zhao, Junjie and Li, Xiaoxia},
title = {A T H 17-intrinsic IL-1β–STAT5 axis drives steroid resistance in autoimmune neuroinflammation},
journal = {Science Immunology},
year = {2024},
doi = {10.1126/sciimmunol.abq1558}
}
EUVIMED